<DOC>
	<DOCNO>NCT00377156</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiation therapy send x-ray directly tumor cause less damage normal tissue . Radiation therapy use high-energy x-ray kill tumor cell . It yet know whether stereotactic radiation therapy effective without whole-brain radiation therapy treat patient brain metastasis . PURPOSE : This randomized phase III trial study stereotactic radiation therapy whole-brain radiation therapy see well work compare stereotactic radiation therapy alone treat patient brain metastasis .</brief_summary>
	<brief_title>Stereotactic Radiation Therapy With Without Whole-Brain Radiation Therapy Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare overall survival patient 1 3 cerebral metastasis treat stereotactic radiosurgery v without whole-brain radiotherapy . Secondary - Compare time CNS ( brain ) failure patient treat regimen . - Compare quality life , duration functional independence , long-term neurocognitive status patient treat regimen . - Compare post-treatment toxicity patient . OUTLINE : This randomize , multicenter study . Patients stratify accord age ( 18 59 v 60 ) , extracranial disease ( control â‰¤ 3 month vs control &gt; 3 month ) , number brain metastasis ( 1 vs 2 v 3 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo stereotactic radiosurgery ( SRS ) . - Arm II : Patients undergo SRS arm I . Within 14 day , patient undergo whole-brain radiotherapy 5 day week 2.5 week . Quality life , functional independence , neurocognitive status assess baseline , begin treatment , week 6 12 , 6 , 9 , 12 , 16 , 24 , 36 , 48 , 60 month . PROJECTED ACCRUAL : A total 238 patient accrue protocol .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cerebral metastasis meet follow criterion : One three presume brain metastasis Metastases must histologically confirm extracerebral site ( e.g. , lung , breast , prostate ) Histologic confirmation may primary tumor site , another metastatic site ( e.g. , osseous metastasis , adrenal metastasis ) , metastatic brain lesion ( ) Each lesion must measure less 3.0 cm contrast MRI brain perform within past 21 day Lesions must within 5 mm optic chiasm within brainstem Eligibility treatment gamma knife linear acceleratorbased radiosurgery confirm radiation oncologist No primary germ cell tumor , small cell carcinoma , lymphoma No leptomeningeal metastases Hormone receptor status specify PATIENT CHARACTERISTICS : Male female Menopausal status specify ECOG performance status 02 Not pregnant Negative pregnancy test Fertile patient must use effective contraception Male patient must continue use contraception 3 month completion radiotherapy No pacemaker MRIincompatible metal body No known allergy gadolinium PRIOR CONCURRENT THERAPY : More 7 day since prior concurrent chemotherapy No prior cranial radiotherapy No prior resection cerebral metastasis Concurrent hormonal agent , steroid , and/or anticonvulsant allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cognitive/functional effect</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>